-
1
-
-
84903541143
-
Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): A randomised controlled trial
-
Vora A, Goulden N, Mitchell C, et al. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2014; 15(8): 809-818.
-
(2014)
Lancet Oncol
, vol.15
, Issue.8
, pp. 809-818
-
-
Vora, A.1
Goulden, N.2
Mitchell, C.3
-
2
-
-
84875273960
-
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): A randomised controlled trial
-
Vora A, Goulden N, Wade R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013; 14(3): 199-209.
-
(2013)
Lancet Oncol
, vol.14
, Issue.3
, pp. 199-209
-
-
Vora, A.1
Goulden, N.2
Wade, R.3
-
3
-
-
41349100708
-
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: Final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
-
Goldstone AH, Richards SM, Lazarus HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood. 2008; 111(4): 1827-1833.
-
(2008)
Blood
, vol.111
, Issue.4
, pp. 1827-1833
-
-
Goldstone, A.H.1
Richards, S.M.2
Lazarus, H.M.3
-
4
-
-
75649092322
-
A populationbased cytogenetic study of adults with acute lymphoblastic leukemia
-
Moorman AV, Chilton L, Wilkinson J, Ensor HM, Bown N, Proctor SJ. A populationbased cytogenetic study of adults with acute lymphoblastic leukemia. Blood. 2010; 115(2): 206-214.
-
(2010)
Blood
, vol.115
, Issue.2
, pp. 206-214
-
-
Moorman, A.V.1
Chilton, L.2
Wilkinson, J.3
Ensor, H.M.4
Bown, N.5
Proctor, S.J.6
-
5
-
-
84860012521
-
Outcomes in older adults with acute lymphoblastic leukaemia (ALL): Results from the international MRC UKALL XII/ECOG2993 trial
-
Sive JI, Buck G, Fielding A, et al. Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. Br J Haematol. 2012; 157(4): 463-471.
-
(2012)
Br J Haematol
, vol.157
, Issue.4
, pp. 463-471
-
-
Sive, J.I.1
Buck, G.2
Fielding, A.3
-
6
-
-
77951441599
-
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFM ALL 2000 study
-
Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010; 115(16): 3206-3214.
-
(2010)
Blood
, vol.115
, Issue.16
, pp. 3206-3214
-
-
Conter, V.1
Bartram, C.R.2
Valsecchi, M.G.3
-
7
-
-
84907080295
-
Targetable kinase-activating lesions in Phlike acute lymphoblastic leukemia
-
Roberts KG, Li Y, Payne-Turner D, et al. Targetable kinase-activating lesions in Phlike acute lymphoblastic leukemia. N Engl J Med. 2014; 371(11): 1005-1015.
-
(2014)
N Engl J Med
, vol.371
, Issue.11
, pp. 1005-1015
-
-
Roberts, K.G.1
Li, Y.2
Payne-Turner, D.3
-
8
-
-
84859209595
-
The clinical relevance of chromosomal and genomic abnormalities in Bcell precursor acute lymphoblastic leukaemia
-
Moorman AV. The clinical relevance of chromosomal and genomic abnormalities in Bcell precursor acute lymphoblastic leukaemia. Blood Rev. 2012; 26(3): 123-135.
-
(2012)
Blood Rev
, vol.26
, Issue.3
, pp. 123-135
-
-
Moorman, A.V.1
-
9
-
-
84878341989
-
Acute lymphoblastic leukaemia
-
Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013; 381 (9881): 1943-1955.
-
(2013)
Lancet
, vol.381
, Issue.9881
, pp. 1943-1955
-
-
Inaba, H.1
Greaves, M.2
Mullighan, C.G.3
-
10
-
-
33644545382
-
Infection, immune responses and the aetiology of childhood leukaemia
-
Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006; 6(3): 193-203.
-
(2006)
Nat Rev Cancer
, vol.6
, Issue.3
, pp. 193-203
-
-
Greaves, M.1
-
11
-
-
78751644099
-
Genetic variegation of clonal architecture and propagating cells in leukaemia
-
Anderson K, Lutz C, van Delft FW, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011; 469(7330): 356-361.
-
(2011)
Nature
, vol.469
, Issue.7330
, pp. 356-361
-
-
Anderson, K.1
Lutz, C.2
van Delft, F.W.3
-
12
-
-
84879593764
-
Genes commonly deleted in childhood Bcell precursor acute lymphoblastic leukemia: Association with cytogenetics and clinical features
-
Schwab CJ, Chilton L, Morrison H, et al. Genes commonly deleted in childhood Bcell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features. Haematologica. 2013; 98(7): 1081-1088.
-
(2013)
Haematologica
, vol.98
, Issue.7
, pp. 1081-1088
-
-
Schwab, C.J.1
Chilton, L.2
Morrison, H.3
-
13
-
-
0141923915
-
Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia
-
Moorman AV, Richards SM, Martineau M, et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood. 2003; 102(8): 2756-2762.
-
(2003)
Blood
, vol.102
, Issue.8
, pp. 2756-2762
-
-
Moorman, A.V.1
Richards, S.M.2
Martineau, M.3
-
14
-
-
34249065493
-
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia
-
Heerema NA, Raimondi SC, Anderson JR, et al. Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 2007; 46(7): 684-693.
-
(2007)
Genes Chromosomes and Cancer
, vol.46
, Issue.7
, pp. 684-693
-
-
Heerema, N.A.1
Raimondi, S.C.2
Anderson, J.R.3
-
15
-
-
20844436312
-
High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: A Children's Oncology Group (COG) initiative
-
Sutcliffe MJ, Shuster JJ, Sather HN, et al. High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. Leukemia. 2005; 19(5): 734-740.
-
(2005)
Leukemia
, vol.19
, Issue.5
, pp. 734-740
-
-
Sutcliffe, M.J.1
Shuster, J.J.2
Sather, H.N.3
-
16
-
-
84878392379
-
Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results
-
Dastugue N, Suciu S, Plat G, et al. Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results. Blood. 2013; 121(13): 2415-2423.
-
(2013)
Blood
, vol.121
, Issue.13
, pp. 2415-2423
-
-
Dastugue, N.1
Suciu, S.2
Plat, G.3
-
17
-
-
84883634157
-
High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols
-
Paulsson K, Forestier E, Andersen MK, et al. High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols. Haematologica. 2013; 98(9): 1424-1432.
-
(2013)
Haematologica
, vol.98
, Issue.9
, pp. 1424-1432
-
-
Paulsson, K.1
Forestier, E.2
Andersen, M.K.3
-
18
-
-
85014252003
-
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia
-
Jabbar Al Obaidi MS, Martineau M, Bennett CF, et al. ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia. 2002; 16(4): 669-674.
-
(2002)
Leukemia
, vol.16
, Issue.4
, pp. 669-674
-
-
Jabbar Al Obaidi, M.S.1
Martineau, M.2
Bennett, C.F.3
-
19
-
-
77952305440
-
Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: Results from the UK Medical Research Council ALL97/99 randomised trial
-
Moorman AV, Ensor HM, Richards SM, et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol. 2010; 11(5): 429-438.
-
(2010)
Lancet Oncol
, vol.11
, Issue.5
, pp. 429-438
-
-
Moorman, A.V.1
Ensor, H.M.2
Richards, S.M.3
-
20
-
-
84904054301
-
High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): Cytogenetic features, clinical characteristics and outcome
-
Chilton L, Buck G, Harrison CJ, et al. High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome. Leukemia. 2014; 28(7): 1511-1518.
-
(2014)
Leukemia
, vol.28
, Issue.7
, pp. 1511-1518
-
-
Chilton, L.1
Buck, G.2
Harrison, C.J.3
-
21
-
-
84887318371
-
Longterm follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor
-
Enshaei A, Schwab CJ, Konn ZJ, et al. Longterm follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor. Leukemia. 2013; 27(11): 2256-2259.
-
(2013)
Leukemia
, vol.27
, Issue.11
, pp. 2256-2259
-
-
Enshaei, A.1
Schwab, C.J.2
Konn, Z.J.3
-
22
-
-
84856756817
-
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: Improved outcome with contemporary therapy
-
Bhojwani D, Pei D, Sandlund JT, et al. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy. Leukemia. 2012; 26(2): 265-270.
-
(2012)
Leukemia
, vol.26
, Issue.2
, pp. 265-270
-
-
Bhojwani, D.1
Pei, D.2
Sandlund, J.T.3
-
23
-
-
84862321772
-
Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12; 21)(p13; q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol
-
Barbany G, Andersen MK, Autio K, et al. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12; 21)(p13; q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol. Leuk Res. 2012; 36(7): 936-938.
-
(2012)
Leuk Res
, vol.36
, Issue.7
, pp. 936-938
-
-
Barbany, G.1
Andersen, M.K.2
Autio, K.3
-
24
-
-
67650421868
-
High hyperdiploid childhood acute lymphoblastic leukemia
-
Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2009; 48(8): 637-660.
-
(2009)
Genes Chromosomes Cancer
, vol.48
, Issue.8
, pp. 637-660
-
-
Paulsson, K.1
Johansson, B.2
-
25
-
-
84962691029
-
Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study
-
Boer JM, Veer Avd, Rizopoulos D, et al. Prognostic Value of Rare IKZF1 deletions in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study. Blood. 2014; 124(21): 368.
-
(2014)
Blood
, vol.124
, Issue.21
, pp. 368
-
-
Boer, J.M.1
Veer Avd, R.D.2
-
26
-
-
84887320453
-
The MLL recombinome of acute leukemias in 2013
-
Meyer C, Hofmann J, Burmeister T, et al. The MLL recombinome of acute leukemias in 2013. Leukemia. 2013; 27(11): 2165-2176.
-
(2013)
Leukemia
, vol.27
, Issue.11
, pp. 2165-2176
-
-
Meyer, C.1
Hofmann, J.2
Burmeister, T.3
-
27
-
-
2942563738
-
Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia
-
Harrison CJ, Moorman AV, Broadfield ZJ, et al. Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia. Br J Haematol. 2004; 125(5): 552-559.
-
(2004)
Br J Haematol
, vol.125
, Issue.5
, pp. 552-559
-
-
Harrison, C.J.1
Moorman, A.V.2
Broadfield, Z.J.3
-
28
-
-
84874647204
-
The genomic landscape of hypodiploid acute lymphoblastic leukemia
-
Holmfeldt L, Wei L, Diaz-Flores E, et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013; 45 (3): 242-252.
-
(2013)
Nat Genet
, vol.45
, Issue.3
, pp. 242-252
-
-
Holmfeldt, L.1
Wei, L.2
Diaz-Flores, E.3
-
29
-
-
34447519040
-
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): An observational study and a multicentre randomised trial
-
Pieters R, Schrappe M, De LP, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007; 370(9583): 240-250.
-
(2007)
Lancet
, vol.370
, Issue.9583
, pp. 240-250
-
-
Pieters, R.1
Schrappe, M.2
De, L.P.3
-
30
-
-
58149398623
-
Translation of the Philadelphia chromosome into therapy for CML
-
Druker BJ. Translation of the Philadelphia chromosome into therapy for CML. Blood. 2008; 112(13): 4808-4817.
-
(2008)
Blood
, vol.112
, Issue.13
, pp. 4808-4817
-
-
Druker, B.J.1
-
31
-
-
84894066916
-
UKALLXII/ECOG2993: Addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia
-
Fielding AK, Rowe JM, Buck G, et al. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood. 2014; 123(6): 843-850.
-
(2014)
Blood
, vol.123
, Issue.6
, pp. 843-850
-
-
Fielding, A.K.1
Rowe, J.M.2
Buck, G.3
-
32
-
-
84865539834
-
Imatinib after induction for treatment of children and adolescents with Philadelphiachromosome-positive acute lymphoblastic leukaemia (EsPhALL): A randomised, openlabel, intergroup study
-
Biondi A, Schrappe M, De Lorenzo P, et al. Imatinib after induction for treatment of children and adolescents with Philadelphiachromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, openlabel, intergroup study. Lancet Oncol. 2012; 13(9): 936-945.
-
(2012)
Lancet Oncol
, vol.13
, Issue.9
, pp. 936-945
-
-
Biondi, A.1
Schrappe, M.2
De Lorenzo, P.3
-
33
-
-
79960044951
-
MLLrearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L
-
Bernt KM, Zhu N, Sinha AU, et al. MLLrearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. Cancer Cell. 2011; 20(1): 66-78.
-
(2011)
Cancer Cell
, vol.20
, Issue.1
, pp. 66-78
-
-
Bernt, K.M.1
Zhu, N.2
Sinha, A.U.3
-
35
-
-
34147135183
-
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 Trial
-
Moorman AV, Harrison CJ, Buck GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 Trial. Blood. 2007; 109(8): 3189-3197.
-
(2007)
Blood
, vol.109
, Issue.8
, pp. 3189-3197
-
-
Moorman, A.V.1
Harrison, C.J.2
Buck, G.A.3
-
36
-
-
84919348129
-
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols
-
Motllo C, Ribera JM, Morgades M, et al. Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols. Cancer. 2014; 120(24): 3958-3964.
-
(2014)
Cancer
, vol.120
, Issue.24
, pp. 3958-3964
-
-
Motllo, C.1
Ribera, J.M.2
Morgades, M.3
-
37
-
-
41949083910
-
Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: Results of Southwest Oncology Group 9400 study
-
Pullarkat V, Slovak ML, Kopecky KJ, Forman SJ, Appelbaum FR. Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood. 2008; 111(5): 2563-2572.
-
(2008)
Blood
, vol.111
, Issue.5
, pp. 2563-2572
-
-
Pullarkat, V.1
Slovak, M.L.2
Kopecky, K.J.3
Forman, S.J.4
Appelbaum, F.R.5
-
38
-
-
33947382184
-
Molecular Cytogenetic Characterisation of TCF3 (E2A)/19p13. 3 Rearrangements in BCell Precursor Acute Lymphoblastic Leukaemia
-
Barber KE, Harrison CJ, Broadfield ZJ, et al. Molecular Cytogenetic Characterisation of TCF3 (E2A)/19p13. 3 Rearrangements in BCell Precursor Acute Lymphoblastic Leukaemia. Genes Chromosomes Cancer. 2007; 46(5): 478-486.
-
(2007)
Genes Chromosomes Cancer
, vol.46
, Issue.5
, pp. 478-486
-
-
Barber, K.E.1
Harrison, C.J.2
Broadfield, Z.J.3
-
39
-
-
0025063464
-
Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications on the t(1; 19)
-
Raimondi S, Behm F, Robertson PK, et al. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications on the t(1; 19). J Clin Oncol. 1990; 8: 1380-1388.
-
(1990)
J Clin Oncol
, vol.8
, pp. 1380-1388
-
-
Raimondi, S.1
Behm, F.2
Robertson, P.K.3
-
40
-
-
68749108126
-
Increased risk for CNS relapse in pre-B cell leukemia with the t(1; 19)/TCF3-PBX1
-
Jeha S, Pei D, Raimondi SC, et al. Increased risk for CNS relapse in pre-B cell leukemia with the t(1; 19)/TCF3-PBX1. Leukemia. 2009; 23(8): 1406-1409.
-
(2009)
Leukemia
, vol.23
, Issue.8
, pp. 1406-1409
-
-
Jeha, S.1
Pei, D.2
Raimondi, S.C.3
-
41
-
-
36348988513
-
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children
-
Kager L, Lion T, Attarbaschi A, et al. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children. Haematologica. 2007; 92(11): 1561-1564.
-
(2007)
Haematologica
, vol.92
, Issue.11
, pp. 1561-1564
-
-
Kager, L.1
Lion, T.2
Attarbaschi, A.3
-
42
-
-
0029867127
-
Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia: Correlations with Hematologic Findings and Outcome. A Collaborative Study of the Groupe Francais de Cytogenetique Hematologique
-
GFCH. Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia: Correlations with Hematologic Findings and Outcome. A Collaborative Study of the Groupe Francais de Cytogenetique Hematologique. Blood. 1996; 87(8): 3135-3142.
-
(1996)
Blood
, vol.87
, Issue.8
, pp. 3135-3142
-
-
GFCH1
-
43
-
-
65649106232
-
Adults with acute lymphoblastic leukemia and translocation (1; 19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy
-
Garg R, Kantarjian H, Thomas D, et al. Adults with acute lymphoblastic leukemia and translocation (1; 19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy. Cancer. 2009; 115(10): 2147-2154.
-
(2009)
Cancer
, vol.115
, Issue.10
, pp. 2147-2154
-
-
Garg, R.1
Kantarjian, H.2
Thomas, D.3
-
44
-
-
84902685650
-
Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia
-
Beldjord K, Chevret S, Asnafi V, et al. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia. Blood. 2014; 123(24): 3739-3749.
-
(2014)
Blood
, vol.123
, Issue.24
, pp. 3739-3749
-
-
Beldjord, K.1
Chevret, S.2
Asnafi, V.3
-
45
-
-
84897528140
-
Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
-
Li Y, Schwab C, Ryan SL, et al. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia. Nature. 2014; 508(7494): 98-102.
-
(2014)
Nature
, vol.508
, Issue.7494
, pp. 98-102
-
-
Li, Y.1
Schwab, C.2
Ryan, S.L.3
-
46
-
-
77957361896
-
Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: Recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group
-
Harrison CJ, Haas O, Harbott J, et al. Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group. Br J Haematol. 2010; 151(2): 132-142.
-
(2010)
Br J Haematol
, vol.151
, Issue.2
, pp. 132-142
-
-
Harrison, C.J.1
Haas, O.2
Harbott, J.3
-
47
-
-
33947257508
-
Prognosis of children with acute lymphoblastic leukaemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21)
-
Moorman AV, Richards SM, Robinson HM, et al. Prognosis of children with acute lymphoblastic leukaemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood. 2007; 109: 2327-2330.
-
(2007)
Blood
, vol.109
, pp. 2327-2330
-
-
Moorman, A.V.1
Richards, S.M.2
Robinson, H.M.3
-
48
-
-
84899979360
-
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): Cytogenetic characterization and outcome
-
Harrison CJ, Moorman AV, Schwab C, et al. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia. 2014; 28(5): 1015-1021.
-
(2014)
Leukemia
, vol.28
, Issue.5
, pp. 1015-1021
-
-
Harrison, C.J.1
Moorman, A.V.2
Schwab, C.3
-
49
-
-
84887513571
-
Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: A comparison of the MRC ALL97/99 and UKALL2003 trials
-
Moorman AV, Robinson H, Schwab C, et al. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials. J Clin Oncol. 2013; 31(27): 3389-3396.
-
(2013)
J Clin Oncol
, vol.31
, Issue.27
, pp. 3389-3396
-
-
Moorman, A.V.1
Robinson, H.2
Schwab, C.3
-
50
-
-
84897568967
-
Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standardrisk children's oncology group studies: A report from the children's oncology group
-
Heerema NA, Carroll AJ, Devidas M, et al. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standardrisk children's oncology group studies: a report from the children's oncology group. J Clin Oncol. 2013; 31(27): 3397-3402.
-
(2013)
J Clin Oncol
, vol.31
, Issue.27
, pp. 3397-3402
-
-
Heerema, N.A.1
Carroll, A.J.2
Devidas, M.3
-
51
-
-
84923900276
-
Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: The experience of the ALLBFM 2000 trial
-
Attarbaschi A, Panzer-Grumayer R, Mann G, et al. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALLBFM 2000 trial. Klin Padiatr. 2014; 226(6-7): 338-343.
-
(2014)
Klin Padiatr
, vol.226
, Issue.6-7
, pp. 338-343
-
-
Attarbaschi, A.1
Panzer-Grumayer, R.2
Mann, G.3
-
52
-
-
84865571594
-
Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: A comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups
-
Attarbaschi A, Morak M, Cario G, et al. Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups. Br J Haematol. 2012; 158(6): 772-777.
-
(2012)
Br J Haematol
, vol.158
, Issue.6
, pp. 772-777
-
-
Attarbaschi, A.1
Morak, M.2
Cario, G.3
-
53
-
-
77949910163
-
Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: Rare clinical curios or potent genetic drivers?
-
Dyer MJ, Akasaka T, Capasso M, et al. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers? Blood. 2010; 115(8): 1490-1499.
-
(2010)
Blood
, vol.115
, Issue.8
, pp. 1490-1499
-
-
Dyer, M.J.1
Akasaka, T.2
Capasso, M.3
-
54
-
-
84902980183
-
IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome
-
Russell LJ, Enshaei A, Jones L, et al. IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome. J Clin Oncol. 2014; 32(14): 1453-1462.
-
(2014)
J Clin Oncol
, vol.32
, Issue.14
, pp. 1453-1462
-
-
Russell, L.J.1
Enshaei, A.2
Jones, L.3
-
55
-
-
38349177862
-
Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray
-
Kawamata N, Ogawa S, Zimmermann M, et al. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood. 2008; 111(2): 776-784.
-
(2008)
Blood
, vol.111
, Issue.2
, pp. 776-784
-
-
Kawamata, N.1
Ogawa, S.2
Zimmermann, M.3
-
56
-
-
44349174780
-
Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease
-
Paulsson K, Cazier JB, Macdougall F, et al. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. Proc Natl Acad Sci USA. 2008; 105(18): 6708-6713.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.18
, pp. 6708-6713
-
-
Paulsson, K.1
Cazier, J.B.2
Macdougall, F.3
-
57
-
-
34249668665
-
Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization
-
Strefford JC, Worley H, Barber K, et al. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization. Oncogene. 2007; 26(29): 4306-4318.
-
(2007)
Oncogene
, vol.26
, Issue.29
, pp. 4306-4318
-
-
Strefford, J.C.1
Worley, H.2
Barber, K.3
-
58
-
-
34147224008
-
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
-
Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature. 2007; 446(7137): 758-764.
-
(2007)
Nature
, vol.446
, Issue.7137
, pp. 758-764
-
-
Mullighan, C.G.1
Goorha, S.2
Radtke, I.3
-
59
-
-
57149118627
-
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia
-
Mullighan CG, Phillips LA, Su X, et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science. 2008; 322(5906): 1377-1380.
-
(2008)
Science
, vol.322
, Issue.5906
, pp. 1377-1380
-
-
Mullighan, C.G.1
Phillips, L.A.2
Su, X.3
-
60
-
-
81155123233
-
Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies
-
Hogan LE, Meyer JA, Yang J, et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 2011; 118(19): 5218-5226.
-
(2011)
Blood
, vol.118
, Issue.19
, pp. 5218-5226
-
-
Hogan, L.E.1
Meyer, J.A.2
Yang, J.3
-
61
-
-
61549114444
-
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia
-
Yang JJ, Bhojwani D, Yang W, et al. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood. 2008; 112(10): 4178-4183.
-
(2008)
Blood
, vol.112
, Issue.10
, pp. 4178-4183
-
-
Yang, J.J.1
Bhojwani, D.2
Yang, W.3
-
62
-
-
19044399684
-
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
-
Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 2002; 1(2): 133-143.
-
(2002)
Cancer Cell
, vol.1
, Issue.2
, pp. 133-143
-
-
Yeoh, E.J.1
Ross, M.E.2
Shurtleff, S.A.3
-
63
-
-
78649742010
-
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
-
Harvey RC, Mullighan CG, Wang X, et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood. 2010; 116 (23): 4874-4884.
-
(2010)
Blood
, vol.116
, Issue.23
, pp. 4874-4884
-
-
Harvey, R.C.1
Mullighan, C.G.2
Wang, X.3
-
64
-
-
43049139905
-
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
-
Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature. 2008; 453(7191): 110-114.
-
(2008)
Nature
, vol.453
, Issue.7191
, pp. 110-114
-
-
Mullighan, C.G.1
Miller, C.B.2
Radtke, I.3
-
65
-
-
70449719091
-
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report
-
Martinelli G, Iacobucci I, Storlazzi CT, et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol. 2009; 27(31): 5202-5207.
-
(2009)
J Clin Oncol
, vol.27
, Issue.31
, pp. 5202-5207
-
-
Martinelli, G.1
Iacobucci, I.2
Storlazzi, C.T.3
-
66
-
-
84897566266
-
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL
-
van der Veer A, Zaliova M, Mottadelli F, et al. IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. Blood. 2014; 123(11): 1691-1698.
-
(2014)
Blood
, vol.123
, Issue.11
, pp. 1691-1698
-
-
van der Veer, A.1
Zaliova, M.2
Mottadelli, F.3
-
67
-
-
84867403265
-
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: Role of IKZF1 deletions and CRLF2 aberrations
-
Buitenkamp TD, Pieters R, Gallimore NE, et al. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia. 2012; 26(10): 2204-2211.
-
(2012)
Leukemia
, vol.26
, Issue.10
, pp. 2204-2211
-
-
Buitenkamp, T.D.1
Pieters, R.2
Gallimore, N.E.3
-
68
-
-
58749109707
-
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
-
Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia. N Engl J Med. 2009; 360(5): 470-480.
-
(2009)
N Engl J Med
, vol.360
, Issue.5
, pp. 470-480
-
-
Mullighan, C.G.1
Su, X.2
Zhang, J.3
-
69
-
-
84881021736
-
What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia?
-
Palmi C, Valsecchi MG, Longinotti G, et al. What is the relevance of Ikaros gene deletions as prognostic marker in pediatric Philadelphia negative B-cell precursor acute lymphoblastic leukemia? Haematologica. 2013; 98(8): 1226-1231.
-
(2013)
Haematologica
, vol.98
, Issue.8
, pp. 1226-1231
-
-
Palmi, C.1
Valsecchi, M.G.2
Longinotti, G.3
-
70
-
-
79751538993
-
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia
-
Waanders E, van der Velden VH, van der Schoot CE, et al. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. Leukemia. 2011; 25(2): 254-258.
-
(2011)
Leukemia
, vol.25
, Issue.2
, pp. 254-258
-
-
Waanders, E.1
van der Velden, V.H.2
van der Schoot, C.E.3
-
71
-
-
84865745212
-
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia
-
Moorman AV, Schwab C, Ensor HM, et al. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. J Clin Oncol. 2012; 30(25): 3100-3108.
-
(2012)
J Clin Oncol
, vol.30
, Issue.25
, pp. 3100-3108
-
-
Moorman, A.V.1
Schwab, C.2
Ensor, H.M.3
-
72
-
-
84891850778
-
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
-
Clappier E, Auclerc MF, Rapion J, et al. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions. Leukemia. 2014; 28(1): 70-77.
-
(2014)
Leukemia
, vol.28
, Issue.1
, pp. 70-77
-
-
Clappier, E.1
Auclerc, M.F.2
Rapion, J.3
-
73
-
-
84891877413
-
ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia
-
Zaliova M, Zimmermannova O, Dorge P, et al. ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia. Leukemia. 2014; 28(1): 182-185.
-
(2014)
Leukemia
, vol.28
, Issue.1
, pp. 182-185
-
-
Zaliova, M.1
Zimmermannova, O.2
Dorge, P.3
-
74
-
-
84859820034
-
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: A Children's Oncology Group study
-
Chen IM, Harvey RC, Mullighan CG, et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2012; 119(15): 3512-3522.
-
(2012)
Blood
, vol.119
, Issue.15
, pp. 3512-3522
-
-
Chen, I.M.1
Harvey, R.C.2
Mullighan, C.G.3
-
75
-
-
84888253484
-
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with Bcell precursor ALL
-
van der Veer A, Waanders E, Pieters R, et al. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with Bcell precursor ALL. Blood. 2013; 122(15): 2622-2629.
-
(2013)
Blood
, vol.122
, Issue.15
, pp. 2622-2629
-
-
van der Veer, A.1
Waanders, E.2
Pieters, R.3
-
76
-
-
85039915681
-
-
Dagdan E, Zaliova M, Dörge P, et al. The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1plus) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment Blood. 2014; 124(21): 131.
-
(2014)
The Strong Prognostic Effect of Concurrent Deletions of IKZF1 and PAX5, CDKN2A, CDKN2B or PAR1 in the Absence of ERG Deletions (IKZF1plus) in Pediatric Acute Lymphoblastic Leukemia Strongly Depends on Minimal Residual Disease Burden after Induction Treatment Blood
, vol.124
, Issue.21
, pp. 131
-
-
Dagdan, E.1
Zaliova, M.2
Dörge, P.3
-
77
-
-
84962669041
-
The Clinical Relevance Of Genetics In Predicting Outcome After a First Relapse In Children With B-Cell Precursor Acute Lymphoblastic Leukaemia
-
Moorman AV, Erhorn A, Parker C, et al. The Clinical Relevance Of Genetics In Predicting Outcome After a First Relapse In Children With B-Cell Precursor Acute Lymphoblastic Leukaemia. Blood. 2013; 122(21): 2566.
-
(2013)
Blood
, vol.122
, Issue.21
, pp. 2566
-
-
Moorman, A.V.1
Erhorn, A.2
Parker, C.3
-
78
-
-
70350519430
-
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
-
Russell LJ, Capasso M, Vater I, et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood. 2009; 114(13): 2688-2698.
-
(2009)
Blood
, vol.114
, Issue.13
, pp. 2688-2698
-
-
Russell, L.J.1
Capasso, M.2
Vater, I.3
-
79
-
-
70350680415
-
Rearrangement of CRLF2 in B-progenitor-and Down syndrome-associated acute lymphoblastic leukemia
-
Mullighan CG, Collins-Underwood JR, Phillips LA, et al. Rearrangement of CRLF2 in B-progenitor-and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet. 2009; 41(11): 1243-1246.
-
(2009)
Nat Genet
, vol.41
, Issue.11
, pp. 1243-1246
-
-
Mullighan, C.G.1
Collins-Underwood, J.R.2
Phillips, L.A.3
-
80
-
-
77949425065
-
Activating mutation in the TSLPR gene in Bcell precursor lymphoblastic leukemia
-
Chapiro E, Russell L, Lainey E, et al. Activating mutation in the TSLPR gene in Bcell precursor lymphoblastic leukemia. Leukemia. 2010; 24(3): 642-645.
-
(2010)
Leukemia
, vol.24
, Issue.3
, pp. 642-645
-
-
Chapiro, E.1
Russell, L.2
Lainey, E.3
-
81
-
-
84864440264
-
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia
-
Tasian SK, Doral MY, Borowitz MJ, et al. Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. Blood. 2012; 120(4): 833-842.
-
(2012)
Blood
, vol.120
, Issue.4
, pp. 833-842
-
-
Tasian, S.K.1
Doral, M.Y.2
Borowitz, M.J.3
-
82
-
-
77954500629
-
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
-
Cario G, Zimmermann M, Romey R, et al. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol. Blood. 2010; 115(26): 5393-5397.
-
(2010)
Blood
, vol.115
, Issue.26
, pp. 5393-5397
-
-
Cario, G.1
Zimmermann, M.2
Romey, R.3
-
83
-
-
77954516863
-
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
-
Harvey RC, Mullighan CG, Chen IM, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010; 115(26): 5312-5321.
-
(2010)
Blood
, vol.115
, Issue.26
, pp. 5312-5321
-
-
Harvey, R.C.1
Mullighan, C.G.2
Chen, I.M.3
-
84
-
-
79951845044
-
Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: Results from the MRC ALL97 clinical trial
-
Ensor HM, Schwab C, Russell LJ, et al. Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. Blood. 2011; 117(7): 2129-2136.
-
(2011)
Blood
, vol.117
, Issue.7
, pp. 2129-2136
-
-
Ensor, H.M.1
Schwab, C.2
Russell, L.J.3
-
85
-
-
84867404417
-
Poor Prognosis for P2RY8-CRLF2 Fusion but not for CRLF2 Over-expression in Children with Intermediate Risk B-Cell Precursor Acute Lymphoblastic Leukemia
-
Palmi C, Vendramini E, Silvestri D, et al. Poor Prognosis for P2RY8-CRLF2 Fusion but not for CRLF2 Over-expression in Children with Intermediate Risk B-Cell Precursor Acute Lymphoblastic Leukemia. Leukemia. 2012; 26(10): 2245-2253.
-
(2012)
Leukemia
, vol.26
, Issue.10
, pp. 2245-2253
-
-
Palmi, C.1
Vendramini, E.2
Silvestri, D.3
-
86
-
-
84871481072
-
Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL
-
Morak M, Attarbaschi A, Fischer S, et al. Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL. Blood. 2012; 120(26): 5134-42.
-
(2012)
Blood
, vol.120
, Issue.26
, pp. 5134-5142
-
-
Morak, M.1
Attarbaschi, A.2
Fischer, S.3
-
87
-
-
84865118132
-
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
-
Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012; 22(2): 153-166.
-
(2012)
Cancer Cell
, vol.22
, Issue.2
, pp. 153-166
-
-
Roberts, K.G.1
Morin, R.D.2
Zhang, J.3
-
88
-
-
84907360666
-
A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia
-
Moorman AV, Enshaei A, Schwab C, et al. A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia. Blood. 2014; 124(9): 1434-1444.
-
(2014)
Blood
, vol.124
, Issue.9
, pp. 1434-1444
-
-
Moorman, A.V.1
Enshaei, A.2
Schwab, C.3
-
89
-
-
58749097408
-
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: A genome-wide classification study
-
Den Boer ML, van Slegtenhorst M, De Menezes RX, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009; 10(2): 125-134.
-
(2009)
Lancet Oncol
, vol.10
, Issue.2
, pp. 125-134
-
-
Den Boer, M.L.1
van Slegtenhorst, M.2
De Menezes, R.X.3
-
90
-
-
85008372514
-
An Analysis Of Ph-Like ALL In Japanese Patients
-
Kiyokawa N, Iijima K, Yoshihara H, et al. An Analysis Of Ph-Like ALL In Japanese Patients. Blood. 2013; 122(21): 352.
-
(2013)
Blood
, vol.122
, Issue.21
, pp. 352
-
-
Kiyokawa, N.1
Iijima, K.2
Yoshihara, H.3
-
91
-
-
85008333473
-
Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience
-
Kronnie Gt, Silvestri D, Vendramini E, et al. Philadelphia-Like Signature In Childhood Acute Lymphoblastic Leukemia: The AIEOP Experience. Blood. 2013; 122(21): 353.
-
(2013)
Blood
, vol.122
, Issue.21
, pp. 353
-
-
Kronnie, G.1
Silvestri, D.2
Vendramini, E.3
-
92
-
-
84962651909
-
BCR-ABL1-Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures
-
Boer JM, Marchante JRM, Horstmann MA, et al. BCR-ABL1-Like Cases In Pediatric Acute Lymphoblastic Leukemia: A Comparison Between COG/St. Jude and Dutch DCOG Signatures. Blood. 2013; 122(21): 2633.
-
(2013)
Blood
, vol.122
, Issue.21
, pp. 2633
-
-
Boer, J.M.1
Marchante, J.R.M.2
Horstmann, M.A.3
-
93
-
-
84901693202
-
ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children
-
Kobayashi K, Mitsui K, Ichikawa H, et al. ATF7IP as a novel PDGFRB fusion partner in acute lymphoblastic leukaemia in children. Br J Haematol. 2014; 165(6): 836-841.
-
(2014)
Br J Haematol
, vol.165
, Issue.6
, pp. 836-841
-
-
Kobayashi, K.1
Mitsui, K.2
Ichikawa, H.3
-
94
-
-
84898466517
-
RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib
-
Lilljebjorn H, Agerstam H, Orsmark-Pietras C, et al. RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib. Leukemia. 2014; 28(4): 977-979.
-
(2014)
Leukemia
, vol.28
, Issue.4
, pp. 977-979
-
-
Lilljebjorn, H.1
Agerstam, H.2
Orsmark-Pietras, C.3
-
95
-
-
84886996732
-
Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion
-
Lengline E, Beldjord K, Dombret H, Soulier J, Boissel N, Clappier E. Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion. Haematologica. 2013; 98(11): e146-148.
-
(2013)
Haematologica
, vol.98
, Issue.11
, pp. e146-e148
-
-
Lengline, E.1
Beldjord, K.2
Dombret, H.3
Soulier, J.4
Boissel, N.5
Clappier, E.6
-
96
-
-
84886513092
-
Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia
-
Weston BW, Hayden MA, Roberts KG, et al. Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia. J Clin Oncol. 2013; 31(25): e413-416.
-
(2013)
J Clin Oncol
, vol.31
, Issue.25
, pp. e413-e416
-
-
Weston, B.W.1
Hayden, M.A.2
Roberts, K.G.3
-
97
-
-
85020160452
-
EBF1-PDGFRB-Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications
-
Schwab C, Andrews R, Chilton L, et al. EBF1-PDGFRB-Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications. Blood. 2014; 124(21): 1068.
-
(2014)
Blood
, vol.124
, Issue.21
, pp. 1068
-
-
Schwab, C.1
Andrews, R.2
Chilton, L.3
-
98
-
-
84962671585
-
SSBP2-CSF1R Is a Recurrent Fusion in BOther Acute Lymphoblastic Leukaemia with Variable Clinical Outcome
-
Schwab C, Andrews R, Chilton L, et al. SSBP2-CSF1R Is a Recurrent Fusion in BOther Acute Lymphoblastic Leukaemia with Variable Clinical Outcome. Blood. 2014; 124(21): 3773.
-
(2014)
Blood
, vol.124
, Issue.21
, pp. 3773
-
-
Schwab, C.1
Andrews, R.2
Chilton, L.3
|